Inventor · disambiguated record
Yao Chen
Also filed as: CHEN YAO · CHEN YAO-KUAN
4 granted patents·13 pending applications·0 citations·filing 2011–2025
53Inventor score
Files withSHENZHEN YANDAI INVEST CO LTD4GLAXOSMITHKLINE IP DEV LTD2NANJING UNIVERSITY OF TECHNOLOGY2UNIV NORTHWESTERN POLYTECHNICAL2BIORAY PHARMACEUTICAL CO LTD1
Top patents by PatentIndex Score
17 records- 0159US2024066511A1Mn-mof-based cold-adapted nanozyme and preparation method thereofUNIV NORTHWESTERN POLYTECHNICAL·Filed 2023·Application pending·0 cites
- 0258US2021379044A1Non peptidic heterobivalent molecules for treating inflammatory diseasesGLAXOSMITHKLINE IP DEV LTD·Filed 2021·Application pending·0 cites
- 0356US2024091366A1Novel acid-sensitive aptamer triptolide conjugate and applicationsUNIV CHENGDU TRADITIONAL CHINESE MEDICINE·Filed 2023·Application pending·0 cites
- 0456US2023293724A1Lyophilized Formulations of AAV Drug ProductsREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0555US2024376160A1Molecular peptide mutant with a high ester bond formation efficiencyNANJING UNIVERSITY OF TECHNOLOGY·Filed 2022·Application pending·0 cites
- 0655US2024002454A1Molecular peptide mutantNANJING UNIVERSITY OF TECHNOLOGY·Filed 2022·Application pending·0 cites
- 0754US2024009258A1Anti-cancer composition and use thereofCHEN YAO KUAN·Filed 2023·Application pending·0 cites
- 0853US2024034804A1ANTI-SIRPa ANTIBODY AND APPLICATION THEREOFBIORAY PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0948US12310944B2Selective butyrylcholinesterase inhibitor or pharmaceutically acceptable salt thereof, preparation method and use thereofUNIV CHINA PHARMA·Filed 2019·Granted May 27, 2025·0 cites·6 claims
- 1048US11452777B2Method for synthesizing a new ferrihydrite nano-photosensitizer and its antibacterial and anticancer useUNIV NORTHWESTERN POLYTECHNICAL·Filed 2019·Granted Sep 27, 2022·0 cites·6 claims
- 1143US2025144131A1Polysaccharide compound with a defined molecular structure for the treatment of pulmonary fibrosisSHENZHEN YANDAI INVEST CO LTD·Filed 2025·Application pending·0 cites
- 1242US2025213701A1Medicament for treating human tumor based on erf3a-targeting proteolysis mechanismSUZHOU DEGEN BIO MEDICAL CO LTD·Filed 2025·Application pending·0 cites
- 1342US2019336489A1Non peptide heterobivalent molecules for treating inflammatory diseasesGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Application pending·0 cites
- 1438US9273127B2P28GANK monoclonal antibody and peptides for preparation thereof and use thereofWANG HONGYANG·Filed 2011·Granted Mar 1, 2016·0 cites·5 claims
- 1528US2025144132A1Polysaccharide compound with a defined molecular structure that can eliminate the toxic side effects of chemotherapy drugsSHENZHEN YANDAI INVEST CO LTD·Filed 2025·Application pending·0 cites
- 1626US12383577B2Polysaccharide compound with a defined molecular structure that can eliminate the toxic side effects of chemotherapy drugsSHENZHEN YANDAI INVEST CO LTD·Filed 2025·Granted Aug 12, 2025·0 cites·13 claims
- 1726US2025144130A1Polysaccharide compound with a defined molecular structure that can eliminate the toxic side effects of chemotherapy drugsSHENZHEN YANDAI INVEST CO LTD·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yao Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →